Skip to main content

Articles Tagged With:

  • Know When to Settle and When to Fight

    With any medical malpractice case, or other lawsuit, the healthcare organization always comes to a decision point about whether to settle or fight the claim in court. Thinking ahead about how to make that decision can help you make the right choice when the time comes.

  • Staying Compliant Can Be Challenging in 2025

    Compliance is always a main concern for healthcare leaders, but some periods can be more challenging than others. Different federal administrations address compliance in different ways, and it is important to understand their particular areas of focus.

  • Drug Diversion Still a Serious Compliance, Patient Safety Issue

    Drug diversion remains as big a problem in healthcare organizations as ever, threatening the safety of patients and quality of care provided by impaired clinicians. Addressing the problem will require a comprehensive effort from risk managers and medical leaders.

  • Influenza and Acute Necrotizing Encephalopathy in Children

    Of 41 U.S. pediatric patients with influenza-associated acute necrotizing encephalitis, 56% were female, the median age was 5 years, and 12% had underlying complex medical conditions. Influenza A accounted for 95% of cases. Despite the use of a variety of immunomodulating agents, 27% of these children died, and 63% of the survivors were left with at least moderate disability.

  • Updates on Cervical Cancer Prevention: Summary and Projected Effect

    HPV vaccination and updated screening strategies offer OB/GYN providers powerful tools to prevent cervical cancer. Recent advances, risk-based management, and enhanced follow-up can provide targeted care for high-risk patients to reduce the incidence of cervical cancer while avoiding unnecessary procedures.

  • Postoperative Antibiotics After Cesarean Delivery to Reduce SSI

    This randomized, double-blind clinical trial including 321 women with a pre-pregnancy body mass index > 30 kg/m2 demonstrated no difference in surgical site infection composite between participants receiving oral cephalexin and metronidazole for 48 hours after cesarean delivery compared to placebo (5.6% vs. 6.8%; odds ratio, 0.80; 95% confidence interval, 0.33-2.22; P = 0.64).

  • Adverse Outcomes in Women with a History of Recurrent Pregnancy Loss

    Women with a history of recurrent pregnancy loss are at significantly increased risk of adverse outcomes, including preeclampsia, placental abruption, cesarean delivery, preterm birth, stillbirth, and perinatal mortality.

  • What Is the Genitourinary Syndrome of Lactation?

    In this systematic review of 65 studies, the prevalence of vaginal atrophy among postpartum breastfeeding patients was 63.9% (95% confidence interval [CI], 55.3% to 71.6%) and vaginal dryness symptoms occurred in 53.6% (95% CI, 33.6% to 72.5%). Dyspareunia also was elevated, with a prevalence of 60.0% at three months, (95% CI, 45.1% to 73.3%), 39.7% at six months, (95% CI, 28.9% to 51.5%), and 28.5% at 12 months (95% CI, 26.3% to 30.9%).

  • Contemporary Cardiovascular Disease Deaths in Asian Americans

    An analysis of a Centers for Disease Control and Prevention database has shown the cardiovascular disease mortality rate is higher in Asian Americans than in non-Asian Americans and that this excess mortality is particularly prevalent in Filipino Americans.

  • Surgery or Fibrinolysis for Thrombosed Mechanical Valves

    A randomized trial of urgent surgery vs. thrombolytic therapy for symptomatic left-sided mechanical valve thrombosis has shown that surgery completely restores valve function in all patients compared to three-quarters of patients with thrombolytic therapy, but at a cost of higher in-hospital complications and mortality.